3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
32
Pain, Postoperative
18
Neoplasms
15
Parkinson Disease 4, Autosomal Dominant Lewy Body
13
Lung Neoplasms
12
Brain Neoplasms
12
Prostatic Neoplasms
9
Ovarian Neoplasms
8
Colonic Neoplasms
8
Carcinoma, Hepatocellular
8
Stomach Neoplasms
7
Depression
7
Colorectal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Pain
6
Head and Neck Neoplasms
6
Thyroid Neoplasms
5
Pancreatic Neoplasms
5
Multiple Myeloma
5
Leiomyoma
5
Agnosia
5
Neoplasm Metastasis
4
Lymphoma
4
Fatigue
4
Delirium
4
Anxiety Disorders
4
Urinary Bladder Neoplasms
3
Thromboembolism
3
Supratentorial Neoplasms
3
Stomatitis
3
Interventions
Fentanyl
2
oxycodone-acetaminophen
1
Tramadol
1
Saline Solution
1
Propofol
1
Orphenadrine
1
Nefopam
1
Morphine
1
Midazolam
1
Methadone
1
Lidocaine
1
Ketorolac Tromethamine
1
Ketorolac
1
Ketamine
1
Hydromorphone
1
Hydrocodone
1
Gabapentin
1
Ertapenem
1
Bupivacaine
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Diverticulosis, Colonic
×
Saline Solution
×
Clear all
NCT03619538
2025-12-01
NEFOPAM
Centre Hospitalier Universitaire de NÄ«mes
Phase NA
Completed
80 enrolled